The global patient blood management market is
foreseen to grow at 7.6%, from USD 12.4 Billion in 2021 to USD 22.3 Billion in
2029. The rising prevalence of target diseases and increasing demand for
donated blood is owing to the growth of the global patient blood management
market. However, the high cost associated with automated systems remains one
factor restraining the market growth for the foreseen period.
Patient blood management (PBM) is a professional
specializations approach to caring for patients who might need a blood
transfusion. The rise in the number of target illnesses augments the demand for
the patient blood management market for the expected future. For example,
according to the American Cancer Society, in 2018, around 17.0 million new
cancer cases were estimated by the International Agency for Research on Cancer
(IARC).
Besides, the increasing number of blood
donations and blood donors is one of the factors seen to propel the market's
growth. For instance, according to the World Health Organization (WHO), in
2020, around 118.5 million blood donations were collected globally. Eventually
increasing the global patient blood management (PBM) market. However, Ongoing
blood drives cancellations due to illness and weather-related closures are
factors to restrain the market growth over the upcoming forecast period.
COVID-19 Impact on Global Patient Blood
Management Market
Active
flu season, the rising number of COVID-19 cases has substantially grown over
the period, increasing the focus of optimizing patient outcomes during the
pandemic. The rising COVID-19 infection has thus led to a positive impact on
the aspects of patient blood management in recent years. Moreover, rising
COVID-19 cases have led to a shortage in the blood supply in the hospitals,
thus creating more demand for patient blood management over the period.
Market
Segmentation
For the
purpose of this report, the global patient blood management market is segmented
on the basis of product type, component type, end-user and region:
Product Outlook (Revenue, USD million;
2018-2029)
|
Instruments
|
Blood Processing Devices
|
Blood Cell Processors
|
|
|
Centrifuge
|
|
Blood Transfusion Devices
|
Apheresis Machines
|
|
|
Cell Salvage Systems
|
|
|
Plasma & Plasma Component Separators
|
|
|
Other Transfusion Devices
|
|
Blood Culture Screening Devices
|
Automated Blood Culture Systems
|
|
|
Supporting Equipment
|
|
Diagnostic & Testing Instruments
|
Blood Grouping Analyzers
|
|
|
Blood Grouping Analyzers
|
|
|
Hematology Analyzer
|
|
|
Next-Generation Sequencing (NGS) Platforms
|
|
|
Polymerase Chain Reaction
|
|
Blood Storage Devices
|
Medical Refrigerators
|
|
|
Medical Freezers
|
Accessories
|
Blood Bags
|
|
Syringes & Needles
|
|
Vials & Tubes
|
|
Other Accessories
|
Reagents and Kits
|
Assay Kits
|
|
Blood Culture Media
|
|
Blood Typing Reagents
|
|
Slide Staining Reagents
|
|
Others
|
Software
|
Blood Bank Management Software
|
|
Transfusion Management Software
|
|
Other Softwares
|
|
|
|
Component Outlook (Revenue, USD million;
2018-2029)
|
Whole Blood & Red Blood Cells
|
Blood Components
|
|
|
|
End User Outlook (Revenue, USD million;
2018-2029)
|
Blood Banks
|
Diagnostic Clinics and & Pathology Labs
|
Hospitals
|
Product
Type Outlook:
On the basis of product
type, the market is segmented into instruments, accessories, reagents and kits,
software. Further, instruments are segmented into blood processing devices, blood
transfusion devices, blood culture screening devices, diagnostic & testing
instruments, blood storage devices. Further, accessories are segmented into
blood bags, syringes & needles, vials & tubes, other accessories.
Further, reagents and kits are segmented into assay kits, blood culture media,
blood typing reagents, slide staining reagents, others. Further, the software
is segmented into blood bank management software, transfusion management
software, and others. The instruments segment holds the most considerable
market share in 2021 due to the increasing number of blood donations and
technological refinements in blood management instruments.
Figure
1 - Patient Blood Management Market, By Product Type (Market Size And Forecast
By Value - USD Million, 2021 & 2029)

Component
Type Outlook:
On the
basis of components, the market is segmented into whole blood & red blood
cells blood components. The whole blood and erythrocytes segment is predicted
to have lucrative growth and significant market share because of growing
disease incidence and rising surgical volumes during the forecast period.
Figure
2 - Component Type Outlook (Revenue, USD Million, 2021)

End-User Outlook:
On the
basis of end-user, the market is segmented into hospitals, blood banks,
diagnostic clinics, and & pathology labs. Stringent Regulatory Compliances
for Established Diagnostic Clinics & Pathology Labs are anticipated to have
a lucrative growth from 2022 to 2029.
Figure 3 - Patient Blood
Management Market, By End User (Market Size and Forecast by Value - USD
Million, 2021 & 2029)

Regional
Outlook (Revenue, USD million; 2021 & 2029)
North
America dominates the global patient blood management market with the rising
cases of cancer in the region. Also, growing surgical procedures with a surge
in the number of accidents in the area are factors propelling the market
growth.
Besides,
emerging nations such as South Africa Brazil, among others, have tremendous
market penetration opportunities as the number of people donating blood is
fewer numbers. For instance, according to the World Health Organization (WHO),
only 1% of the population in South Africa donate blood. Various blood donation
camps and strategies by the South African National Blood Services (SANBS) have
led to improved transfusion practices of blood supply in the region. Thus
growing the demand for patient blood management market over the forecast
period.